B.Riley FBR analyst Mayank Mamtani maintained a Buy rating on Medicines Co (MDCO – Research Report) today and set a
Tag: Medicines Co.
B.Riley FBR Sticks to Their Buy Rating for Medicines Co (MDCO)
B.Riley FBR analyst Mayank Mamtani reiterated a Buy rating on Medicines Co (MDCO – Research Report) yesterday and set a
Cowen & Co. Reiterates a Buy Rating on Medicines Co (MDCO)
In a report released today, Chris Shibutani from Cowen & Co. reiterated a Buy rating on Medicines Co (MDCO –
Medicines Co (MDCO) Received its Third Buy in a Row
After Cowen & Co. and Chardan Capital gave Medicines Co (NASDAQ: MDCO) a Buy rating last month, the company received
Medicines Co (MDCO) Received its Third Buy in a Row
After Cowen & Co. and Citigroup gave Medicines Co (NASDAQ: MDCO) a Buy rating last month, the company received another
Chardan Capital Reiterates a Buy Rating on Medicines Co (MDCO)
Chardan Capital analyst Gbola Amusa reiterated a Buy rating on Medicines Co (MDCO – Research Report) today and set a
Medicines Co (MDCO) Received its Third Buy in a Row
After Jefferies and Chardan Capital gave Medicines Co (NASDAQ: MDCO) a Buy rating last month, the company received another Buy,